Medpace’s Post

Review the clinical data and real-world experiences presented at the 41st Congress of the ESCRS on Vivinex Gemetric and Vivinex Gemetric Plus IOLs (HOYA Surgical Optics). Erik L. Mertens, MD, FEBO, PCEO, FWCRS, moderated a panel consisting of: Bob Anello; Hakan Kaymak, MD; Ramón Ruiz Mesa, MD, FWCRS; and Dylan A. Joseph, MBChB, Dip(Ophth), FC Ophth, MMed, FWCRS. Read their thoughts on the impressive results in both clinical trials and the real world. #sponsored https://bit.ly/3QGcInD

🔬Advancing Diagnostics: The Future of Microscopy 🌍 As we wrap up our 30-year celebration series, we're proud to reflect on CellaVision's remarkable journey of innovation in digital microscopy. Over the last three decades, we've transformed the landscape of diagnostics, driving improvements in speed, accuracy, and efficiency for healthcare providers around the world. "As we mark this milestone, our commitment to innovation and excellence remains unwavering. Here’s to the next 30 years of advancing the future of microscopy and the efficiency of healthcare globally." – Simon Østergaard, President & CEO. A major focus for the future centers on the groundbreaking Fourier Ptychographic Microscopy (FPM), acquired in 2021. This cutting-edge technology generates high-resolution images using low-magnification optics, opening new possibilities beyond hematology. These developments have the potential to revolutionize microscopy and enhance patient care on a global scale. We look forward to the future with optimism and determination. We're committed to continuing to innovate and push the boundaries of what’s possible to make healthcare more efficient and accessible worldwide. 🚀 

Ophthopedia Update:VIDEO: Canyon Labs’ acquisition of iuvo Bioscience will help drive ophthalmic research: KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Ben Burton of iuvo Bioscience sheds light on how the acquisition of the company’s lab services by Canyon Labs will aid its mission to drive ophthalmic research. “We are going to continue to focus all of our investment, people and hiring specifically and solely on ophthalmic clinical research — front of the eye, back of the eye and regulatory all the way through strategy development and commercialization,” he said. #ophthalmology #eye #eyenews

🔬 Curious about the journey #radiopharmaceuticals embark on before becoming integral to medical practice? ☢️ Check out Leila Safavi PhD article that shed light on the intricate process that shapes Radiopharmaceuticals. The fusion of cutting-edge science and medical innovation, fueling progress in diagnostic imaging and targeted therapies. Explore this article and more in the latest edition of Radiotheranostics Today, access it here https://buff.ly/3vhvlXE Many thanks to our esteemed ambassador Leila Safavi, PhD for her valuable contribution. #radiopharmaceuticals #nuclearmedicine #modernmedicine #radiotheranostics

#NYCU Demonstrates Research Excellence in 2024 with Breakthrough #Medical #Imaging Technologies National Yang Ming Chiao Tung University (#NYCU) in Taiwan has once again showcased its research prowess in 2024. The university successfully obtained Quality Management System (#QMS) certification for three cutting-edge intelligent medical imaging systems: the AI Brain Tumor Detection System, the Critical Care Early Warning Platform, and the Anesthetic Transmission Puncture Needle. This achievement positions NYCU as one of the few institutions in Taiwan holding multiple QMS certifications alongside licenses for manufacturing and selling medical devices. It underscores NYCU’s leading role in medical device R&D and commercialization while strengthening the foundation for industry-academia collaboration. For complete reading, https://lnkd.in/gw-bMSw2

Lab Innovators in Europe Have Solutions for USA Many of the diagnostic products sold here were first developed and used in other countries IN RECENT WEEKS, THE DARK REPORT COMPLETED A FACT-FINDING TRIP to medical laboratories and lab vendors in several European nations. Conversations with clinical laboratory leaders and anatomic pathologists confirmed that healthcare systems in their countries are dealing with what can be characterized as “universal challenges.” Stated differently, the same fundamental market dynamics shaping the delivery of medical services here in the United States are equally at play in The Netherlands, Germany, and Italy—the three countries your Editor-In-Chief visited on this trip. This is relevant for an important reason. Except for the fact that the same fundamental problems of providing medical care exist in most developed nations, new technologies and new clinical innovations surfacing in these same countries have the ability to address identical problems in all of those nations. This will be true of clinical laboratory testing and anatomic pathology services. For instance, when a new diagnostic technology emerges within the European Union, demonstrates that it improves patient care, and earns an EU Mark, it can be expected that... Read the newest issue of The Dark Report Now! https://hubs.ly/Q02RHX4S0 Need A Group Membership? Company Discounts are Available! https://hubs.ly/Q02RJ1Pw0

🔍 𝐇𝐨𝐰 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐚𝐫𝐞 𝐲𝐨𝐮𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐬𝐭𝐞𝐫𝐧𝐨𝐭𝐨𝐦𝐲 𝐜𝐥𝐨𝐬𝐮𝐫𝐞? 💡 Considerations: 🔹𝐓𝐡𝐞 𝐄𝐑𝐀𝐒 𝐠𝐮𝐢𝐝𝐞𝐥𝐢𝐧𝐞 suggests rigid fixation for high-risk patients, citing a randomised controlled trial (RCT) that reported better healing, fewer complications, and improved outcomes —all at no additional cost after six months. 🔹𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐂𝐥𝐚𝐬𝐬𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧: The MUST score (MalUnion of STernum) helps categorise patients into low, medium, and high-risk groups, allowing for a more tailored and effective surgical approach. 🔹𝐅𝐥𝐞𝐱𝐢𝐛𝐥𝐞 𝐂𝐡𝐨𝐢𝐜𝐞𝐬: Select between wire cerclage or rigid fixation based on patient needs, ensuring optimal care and cost-effectiveness. 🎥 Watch Anytime: Access our webinar 👇 featuring insights from leading cardiothoracic surgeons in the UK and Switzerland. They explore these strategies in depth, offering practical guidance to enhance your practice. #CardiacSurgery #PatientCare #SurgicalInnovation #SternalClosure 𝘍𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘰𝘯 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘪𝘭𝘪𝘵𝘺, 𝘱𝘭𝘦𝘢𝘴𝘦 𝘳𝘦𝘢𝘤𝘩 𝘰𝘶𝘵 𝘵𝘰 𝘺𝘰𝘶𝘳 𝘭𝘰𝘤𝘢𝘭 𝘴𝘢𝘭𝘦𝘴 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘷𝘦.

A case study of expertise and efficiency. MCRA, an IQVIA business’s AI & Imaging Center team collaborated with its Clinical and Regulatory Affairs divisions to deliver accelerated FDA clearance of a groundbreaking #radiology #technology from United Imaging Intelligence. MCRA’s operational #expertise and seamless integration ensured the study had zero deficiencies — resulting in the approval of their client’s uAI Easy Triage ICH software in under 60 days. #MCRA #AITechnology #FDA #FDAExperts #Medicare #MedicalDevice Get advice from former FDA experts about your AI/ML device submission. Talk to our experts. https://lnkd.in/g-NeA6pk

Ophthopedia Update:VIDEO: Canyon Labs’ acquisition of iuvo Bioscience will help drive ophthalmic research: KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Ben Burton of iuvo Bioscience sheds light on how the acquisition of the company’s lab services by Canyon Labs will aid its mission to drive ophthalmic research. “We are going to continue to focus all of our investment, people and hiring specifically and solely on ophthalmic clinical research — front of the eye, back of the eye and regulatory all the way through strategy development and commercialization,” he said.

Lab Innovators in Europe Have Solutions for USA Many of the diagnostic products sold here were first developed and used in other countries IN RECENT WEEKS, THE DARK REPORT COMPLETED A FACT-FINDING TRIP to medical laboratories and lab vendors in several European nations. Conversations with clinical laboratory leaders and anatomic pathologists confirmed that healthcare systems in their countries are dealing with what can be characterized as “universal challenges.” Stated differently, the same fundamental market dynamics shaping the delivery of medical services here in the United States are equally at play in The Netherlands, Germany, and Italy—the three countries your Editor-In-Chief visited on this trip. This is relevant for an important reason. Except for the fact that the same fundamental problems of providing medical care exist in most developed nations, new technologies and new clinical innovations surfacing in these same countries have the ability to address identical problems in all of those nations. This will be true of clinical laboratory testing and anatomic pathology services. For instance, when a new diagnostic technology emerges within the European Union, demonstrates that it improves patient care, and earns an EU Mark, it can be expected that... Read the newest issue of The Dark Report Now! https://hubs.ly/Q02RJ1W-0 Need A Group Membership? Company Discounts are Available! https://hubs.ly/Q02RHQM-0